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Introduction
In mammals the interface between the body and the external
environment is the epidermis, comprising a multilayered
epithelium (the interfollicular epidermis) and associated
appendages: hair follicles, sebaceous glands and sweat glands
(Watt, 2001). It is not only a complex, but also a very dynamic,
tissue because there is rapid cell turnover in the interfollicular
epidermis (IFE) and hair follicles undergo cyclic phases of
growth (anagen), regression (catagen) and rest (telogen).
Maintenance of the epidermis depends on a population of
multipotential stem cells that have the ability to generate all of
the differentiated epidermal lineages (Niemann and Watt,
2002). The epidermis is a frequent target for oncogenic
mutations and it is thought that stem cells are responsible for
the production of most epidermal tumours because, as long-
term tissue residents, they can accumulate multiple mutations
and undergo clonal expansion (Perez-Losada and Balmain,
2003; Owens and Watt, 2003).
In recent years there has been tremendous progress in
identifying the genetic and molecular changes occurring
during malignant transformation. Abnormal b -catenin
signalling, resulting from genetic alterations that act by
stabilising b -catenin, have been implicated in many cancers,
including colorectal and hepatocellular cancer, melanoma and
tumours of hair follicles (reviewed by Polakis, 2000). b -
catenin is a structural component of adherens junctions,
linking cadherins to the actin cytoskeleton, and is also the key
effector of Wnt signalling, which plays a role during
development of many tissues (Peifer and Polakis, 2000). In the
absence of Wnt, the cytoplasmic pool of b -catenin that is not
complexed with cadherins is rapidly phosphorylated at the N
terminus by glycogen synthase kinase 3 b (GSK-3 b ) and
ubiquitinated, resulting in its degradation. Wnt, through its
receptor frizzled, inhibits GSK-3 b , so that b -catenin
accumulates in the cytoplasm and eventually translocates to
the nucleus  (Henderson and Fagotto, 2002). There it interacts
with the N terminus of transcription factors of the Tcf/Lef
family and regulates transcription of target genes (Huelsken
and Birchmeier, 2001; Brantjes et al., 2002; Moon et al.,
2002).
Several Wnts and their Frizzled receptors are expressed in
the epidermis in a highly dynamic and complex pattern (Reddy
When b -catenin signalling is disturbed from mid-gestation
onwards lineage commitment is profoundly altered in
postnatal mouse epidermis. We have investigated whether
adult epidermis has the capacity for b -catenin-induced
lineage conversion without prior embryonic priming. We
fused N-terminally truncated, stabilised b -catenin to the
ligand-binding domain of a mutant oestrogen receptor
(D Nb -cateninER). D Nb -cateninER was expressed in the
epidermis of transgenic mice under the control of the
keratin 14 promoter and b -catenin activity was induced in
adult epidermis by topical application of 4-
hydroxytamoxifen (4OHT). Within 7 days of daily 4OHT
treatment resting hair follicles were recruited into the hair
growth cycle and epithelial outgrowths formed from
existing hair follicles and from interfollicular epidermis.
The outgrowths expressed Sonic hedgehog, Patched and
markers of hair follicle differentiation, indicative of de novo
follicle formation. The interfollicular epidermal
differentiation program was largely unaffected but after an
initial wave of sebaceous gland duplication sebocyte
differentiation was inhibited. A single application of 4OHT
was as effective as repeated doses in inducing new follicles
and growth of existing follicles. Treatment of epidermis
with 4OHT for 21 days resulted in conversion of hair
follicles to benign tumours resembling trichofolliculomas.
The tumours were dependent on continuous activation of
b -catenin and by 28 days after removal of the drug they
had largely regressed. We conclude that interfollicular
epidermis and sebaceous glands retain the ability to be
reprogrammed in adult life and that continuous b -catenin
signalling is required to maintain hair follicle tumours.
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et al., 2001). In postnatal epidermis two members of the
Tcf/Lef family are expressed: Tcf3 in the bulge and outer root
sheath (ORS) of the hair follicle, and Lef1 in the ORS and
matrix cells (DasGupta and Fuchs, 1999; Merrill et al., 2001).
Using an artificial promoter constructed of multimeric
Lef1/Tcf binding sites as a reporter of Wnt responsive cells,
promoter activity is observed during hair follicle formation in
embryonic skin and postnatally, both in the hair follicle bulge,
a reservoir of stem cells, and in hair shaft precursor cells
(DasGupta and Fuchs, 1999).
There is considerable evidence that b -catenin signalling is
important in epidermal development, homeostasis and disease
(reviewed by Fuchs et al., 2001). Mice expressing stabilised,
N-terminally truncated b -catenin under the control of the
keratin 14 (K14) promoter produce an excess of hair follicles
and develop tumours similar to human pilomatricomas and
trichofolliculomas (Gat et al., 1998). In humans these benign
tumours are associated with activating mutations of b -catenin
(Chan et al., 1999). Conversely, if b -catenin is conditionally
deleted in the skin during embryogenesis there is no hair
formation, and if the deletion occurs after birth the hair is lost
after the first hair cycle (Huelsken et al., 2001). Hair follicle
development is also prevented when Dickkopf 1, an inhibitor
of Wnt action, is ectopically expressed (Andl et al., 2002) or
when the Lef1 gene is ablated in the epidermis (van Genderen
et al., 1994). Transgenic mice in which the Wnt pathway is
blocked by expressing N-terminally truncated Lef1 in the
epidermis have progressive hair loss and develop epidermal
cysts with interfollicular and sebocyte differentiation (Merrill
et al., 2001; Niemann et al., 2002). When a stabilised form of
b -catenin lacking the C-terminal transactivation domain is
expressed in the epidermis hair differentiation is promoted in
the interfollicular epidermis and hair follicles develop cysts of
interfollicular epidermis; this appears to reflect the status of the
endogenous b -catenin/Tcf/Lef complexes in the cells
(DasGupta et al., 2002).
These observations clearly establish that b -catenin plays a
fundamental role in morphogenesis of the hair follicle and
strongly suggest that the level of b -catenin signalling
determines whether keratinocytes differentiate along the hair
or interfollicular/sebocyte lineages. However, the keratin 14
and keratin 5 promoters used for many of the transgenic
mouse studies are active during embryogenesis and indeed
K5 and K14 expression is detected at E9.5, as early as the
single layered ectodermal stage (Byrne et al., 1994). This
raises the possibility that the epidermis is only competent to
respond to altered b -catenin signalling in postnatal life if it
has undergone some form of reprogramming during
embryogenesis, analogous to T cell priming (Melief, 2003).
Indeed the major effect of transient activation of b -catenin in
adult epidermis appears to be to promote anagen (growth)
phase of the hair cycle (Van Mater et al., 2003). In addition,
experiments with cultured human interfollicular epidermis
suggest that b -catenin may act primarily to alter stem cell
number rather than to direct lineage commitment: the putative
stem cells express high levels of cytoplasmic b -catenin, and
expression of stabilised b -catenin expands the stem cell
compartment, while inhibition of b -catenin signalling
promotes exit from the stem cell compartment (Zhu and Watt,
1996; Zhu and Watt, 1999). The concept that b -catenin might
act primarily to control stem cell number has recently
received support from studies on haemopoiesis (Reya et al.,
2003).
The goal of our experiments was to establish whether
activation of b -catenin signalling exclusively in adult
epidermis is sufficient to induce de novo hair follicle
formation and hair follicle tumours. In addition we wanted to
obtain information as to the timing and duration of b -catenin
signals required for these effects. We used the K14 promoter
to drive expression of a chimeric protein in which N-
terminally truncated b -catenin is fused with an engineered
form of the ligand binding domain of the oestrogen receptor
(ER), which is insensitive to endogenous oestrogen
(Littlewood et al., 1995). In this way, the site and timing of b -
catenin activation is easily controlled by topical application of
the synthetic steroid 4-hydroxytamoxifen (4OHT) to the skin
of transgenic mice (Arnold and Watt, 2001; Van Mater et al.,
2003).
Materials and methods
Transgene construction
The D Nb -cateninER construct was generated by in frame insertion of
N-terminally truncated b -catenin cDNA (nucleotides 715-2604, T2)
(Funayama et al., 1995; Zhu and Watt, 1999) into the BamHI site of
the retroviral vector pBabepuro (Morgenstern and Land, 1990)
containing the hormone-binding domain of a mutant murine oestrogen
receptor (Littlewood et al., 1995).
To generate the transgene construct, D Nb -cateninER was excised
from pBabepuro, blunt-ended with Klenow DNA polymerase and
cloned into the blunt-ended BamHI site of a K14 expression cassette
generously provided by E. Fuchs, Howard Hughes Medical Institute,
Rockefeller University, New York (Vasioukhin et al., 1999). The K14
expression cassette (Fig. 1A) contains a 2100 bp AvaI fragment of the
keratin 14 promoter/enhancer, a rabbit b -globin 5 ¢ untranslated region
(UTR), together with an intronic sequence upstream of a BamHI site,
and the K14 3¢ UTR, followed by a polyadenylation site 3 ¢
downstream of the BamHI site. The transgene construct was excised
from the pBabe vector as an EcoRI/HindIII fragment, gel purified
(Geneclean, Stratech Scientific), further purified with an elutip
column according to the manufacturer’s instructions (Schleicher and
Schuell), and then resuspended at a concentration of 5 m g/ml in sterile
injection buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 7.4) for
pronuclear injection.
Generation of transgenic mice and determination of copy
number
The transgene construct was injected into the male pronucleus of day-
1 fertilised (CBA · C57BL/6) F1 embryos. Founders were
backcrossed to establish lines of animals. Animals were screened for
the presence of the transgene by PCR of tail DNA with primers
specific for the transgene (one primer specific for ER,
GCACACAAACTCTTCACC; the other specific for b -catenin,
ATGCTGCTGGCTGGCTATGGTCAG). To determine transgene
copy number Southern blotting was performed on genomic DNA
isolated from tail snips and digested overnight with EcoRV. Blots were
probed with a radiolabelled 1.9 kb b -catenin cDNA probe and with a
probe to the single copy gene interleukin 2 receptor a , as described
previously (Carroll et al., 1995).
Experimental treatments of mice
At the start of every experiment all the mice were 6-8 weeks old, and
therefore in the resting phase of the hair cycle (Stenn and Paus, 2001).
The D Nb -cateninER transgene was activated by topical application of
4-hydroxytamoxifen (4OHT; Sigma) to a clipped area of dorsal skin
(4OHT was dissolved in acetone; dose: 1 mg per mouse per day).
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Wild-type littermates were used as controls. No sex-specific effects of
4OHT were observed. In some experiments mice received an
intraperitoneal injection of BrdU (0.1 mg/g body weight) 1 hour prior
to sacrifice.
Cell culture
Keratinocytes were isolated from transgenic and wild-type newborn
mouse skin and cultured at 32°C in a humidified atmosphere with
5% CO2 in low calcium FAD medium containing 10% chelated
FCS and a cocktail of 0.5 m g/ml hydrocortisone, 5 m g/ml insulin,
10–10 M cholera toxin and 10 ng/ml EGF. The methods were
essentially as described previously (Carroll et al., 1995; Roper et al.,
2001), except that the skin trypsinisation procedure was carried out
at 4°C and disaggregation of keratinocytes was performed without
stirring.
Phoenix and AM12 retroviral packaging lines and NIH 3T3 cells
were cultured in DMEM containing 10% donor calf serum at 37°C in
a humidified atmosphere with 5% CO2.
Retroviral infection and luciferase assays
Retroviral vectors encoding D Nb -cateninER or GFP (Lowell et al.,
2000) were packaged using a two step procedure involving transient
transfection of ecotropic Phoenix cells (Swift et al., 1999) and
infection of amphotropic AM12 cells with viral supernatant from the
Phoenix cultures (Zhu and Watt, 1999; Watt et al., 2004). NIH 3T3
cells were infected overnight at 32°C with supernatant from
transduced AM12 cells and selected with puromycin (2.0 m g/ml) to
achieve close to 100% transduction efficiency.
The following Promega luciferase reporter constructs were used:
pRL (Renilla luciferase control), TOPFLASH (firefly luciferase) and
FOPFLASH (firefly luciferase) (van de Wetering et al., 1997).
Transient transfections of NIH 3T3 cells transduced with D Nb -
Fig. 1. Characterisation of the
D Nb -cateninER fusion protein
and generation of transgenic
mice. (A) Schematic diagram
showing the K14 expression
cassette and D Nb -cateninER
transgene. (B) Anti-ER
immunofluorescence staining of
3T3 cells expressing D Nb -
cateninER following treatment
with ethanol or 4OHT for 24
hours. (C) The induction of
luciferase activity after 4OHT
treatment. 3T3 cells were
transduced with GFP or D Nb -
cateninER and transiently
transfected with the luciferase
reporters FOPFLASH or
TOPFLASH. The luciferase
activity of each reporter was
measured in triplicate and the s.d.
is shown. (D) Anti-ER
immunofluorescence staining
(green) of wild-type and
transgenic K14 D Nb -cateninER
(line D4) mouse back skin,
untreated and after 7 days
treatment with 4OHT. Nuclei
were stained with propidium
iodide (red). Insets show higher
magnification views of boxed
areas. (E) Western blot of primary
keratinocytes cultured from wild-
type (WT) and transgenic (lines
3953 and D4) mice, probed with
anti-ER (top panel) or, as a
loading control, anti-Erk MAPK
(bottom panel) antibodies.
(F) Gross phenotype of wild-type
and D Nb -cateninER mice (line
D2) treated daily for 14 days with
4OHT, showing dramatic
stimulation of hair growth in the
transgenic mouse. Scale bars:
(B) 50 m m, (D) 100 m m (main
pictures), 25 m m (inserts).
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cateninER or GFP retroviral vectors were performed using Superfect
Transfection Reagent (Qiagen). Cells were extracted using Passive
Lysis Buffer (Promega), enabling both firefly and Renilla luciferase
measurements to be performed on the same extracts. Luciferase assays
were performed according to the manufacturer’s instructions using the
Dual-Luciferase Reporter Assay kit (Promega) on a BioOrbit 1251
luminometer. All measurements were made in triplicate and corrected
for transfection efficiency.
Antibodies
Antibodies against the following antigens were used: b -catenin (clone
15B8; Sigma), BrdU (Becton Dickinson), CCAAT displacement
protein (CDP; a gift from M. Busslinger) (Ellis et al., 2001), cyclin
D1 (Zymed), oestrogen receptor (MC-20; Santa Cruz Biotechnology
or HL-7) (Arnold and Watt, 2001), Erk2 (sc-1647; Santa Cruz
Biotechnology), fatty acid synthase (IBL), keratin 1 (Covance),
keratin 10 (Covance), keratin 17 (a gift from P. Coulombe) (McGowan
and Coulombe, 1998), Lef1 (Upstate) and trichohyalin (AE15; a gift
from Tung-Tien Sun) (O’Guin et al., 1992). Additionally, we
generated the polyclonal antibody ERP2 by injecting rabbits with a
peptide (AHSLQTYYIPPEAEGFPNTI) corresponding to the C
terminus of the murine oestrogen receptor, which was previously used
to generate the HL-7 antibody (Arnold and Watt, 2001). Goat anti-
rabbit and anti-mouse Alexa 488 conjugated IgG (Molecular Probes)
and biotinylated goat anti-rabbit IgG (Vector Laboratories) were used
as secondary antibodies.
Histochemistry, immunohistochemistry and in situ
hybridisation
Tissue samples for immunohistochemistry were either fixed overnight
in neutral buffered formalin and embedded in paraffin wax, or frozen,
unfixed, in OCT compound (Miles, Elkhart, USA) on a frozen
isopentane surface (cooled with liquid nitrogen). 5 m m sections were
prepared and stained with Haematoxylin and Eosin.
Immunohistochemistry for CDP, fatty acid synthase and the
keratins was performed on paraffin wax sections as described
previously (Niemann et al., 2002). Briefly, antigen retrieval was
performed by microwaving in 10 mM citrate buffer (pH 6) for 20
minutes and non specific binding was blocked by incubating the
sections in 10% goat serum (Sigma) for 1 hour. Polyclonal primary
antibodies were diluted in PBS or TBS containing 1% BSA (ICN) and
detected using biotinylated secondary antibody (Vector Laboratories),
streptavidin complex with horseradish peroxidase (Dako) and DAB
(Sigma). For immunostaining of cyclinD1, trichohyalin and Lef1 the
Mouse on Mouse kit (Vector Laboratories) was used following the
manufacturer’s instructions. Haematoxylin was used as a nuclear
counterstain.
BrdU-labelled cells were detected in paraffin wax-embedded
sections that had been treated sequentially with HCl and trypsin (Kim
et al., 1997), using a mouse monoclonal antibody to BrdU (Becton
Dickinson) and Alexa 488-conjugated goat anti-mouse IgG. To detect
ER expression, 10 m m frozen sections were fixed in 3%
paraformaldehyde (Sigma) for 10 minutes, permeabilized with 0.2%
Triton X-100 (Sigma) for 5 minutes, incubated for 90 minutes in 10%
goat serum (Sigma) in PBS, then for 40 minutes with the ER
antibodies and finally with the Alexa 488-conjugated goat anti-rabbit
IgG (Molecular Probes). b -catenin was visualised in the same way as
ER, except that the Mouse on Mouse kit (Vector Laboratories) was
used. Nuclei were labelled with propidium iodide and preparations
were analysed on a Zeiss 510 confocal microscope.
Alkaline phosphatase activity was visualised in frozen sections with
the NBT-BCIP method (Filipe and Lake, 1990). Briefly, the sections
were incubated in NTMT buffer (100 mM Tris-HCl pH 9.5, 50 mM
MgCl2, 100 mM NaCl, 0.1% Triton X-100) containing 4.5 m l/ml nitro
blue tetrazoliun chloride (Roche) and 3.5 m l/ml 5-bromo-4-chloro-3-
indolyl phosphate (Roche), counterstained with Fast Red and mounted
in Permount (Fischer Scientific).
In situ hybridisation was performed as described previously
(Poulsom et al., 1998), using 35S-labelled riboprobes to Sonic
hedgehog (Shh) and Patched (Ptc), kindly provided by B. Spencer-
Dene (Revest et al., 2001). Hybridisation with a b -actin antisense
probe served as a positive control.
Western blotting
Primary mouse keratinocytes were cultured to confluence, then lysed
in RIPA buffer (50 mM Tris HCl pH7.4, 1% NP40, 0.25% sodium
deoxycholate, 150 mM NaCl, 1 mM EGTA). Protein concentrations
were determined using a BCA protein assay kit (Pierce). Protein
lysates (20 m g) were separated on a SDS-PAGE gel, transferred to a
PVDF membrane (Amersham) by electroblotting, blocked in 5% non
fat dried milk (Marvel, Cadbury), incubated with primary antibody
and visualised with appropriate horseradish peroxidase-coupled
secondary antibodies using enhanced chemiluminescence (ECL;
Amersham).
Results
Generation of transgenic mice expressing D Nb -
cateninER
In order to control the timing and duration of b -catenin
activation we generated a construct in which a stabilised form
of b -catenin was fused to the ligand binding domain of a
mutant oestrogen receptor. b -catenin was stabilised by deletion
of the N-terminal 147 amino acids, thereby removing the GSK-
3b phosphorylation sites that target the protein for degradation
(Clevers and van de Wetering, 1997; Zhu and Watt, 1999). The
C terminus of D Nb -catenin was fused to the N terminus of a
form of the ligand binding domain of the oestrogen receptor
which is insensitive to endogenous oestrogen but responds to
the synthetic steroid 4-hydroxytamoxifen (4OHT) (Littlewood
et al., 1995; Gandarillas and Watt, 1997; Arnold and Watt,
2001).
b -cateninER chimeras have previously been shown to retain
b -catenin activity (Weng et al., 2002; Kolligs et al., 2002; Van
Mater et al., 2003). To establish that this was also the case for
our construct we introduced D Nb -cateninER into a retroviral
vector and transduced NIH 3T3 cells (Fig. 1B). As predicted,
in the absence of 4OHT the chimeric protein was expressed
and accumulated primarily in the cytoplasm, where it was
detected with an antibody to the mutant oestrogen receptor
(Fig. 1B, left hand panel). When cells were treated with 4OHT
the cytoplasmic staining was reduced and the chimera was
localised predominantly in the nucleus (Fig. 1B, right hand
panel). This change in the expression pattern was expected,
since in the absence of 4OHT the ER is complexed with heat
shock proteins in the cytoplasm (Littlewood et al., 1995).
To examine whether D Nb -cateninER could activate
transcription of Lef/Tcf target genes we retrovirally transduced
3T3 cells with the D Nb -cateninER construct or with GFP
(Lowell et al., 2000) and we transfected them with a luciferase
construct containing an enhancer with multiple Lef1/Tcf-
binding sequences (TOP) (van de Wetering et al., 1997). As a
negative control we used a reporter construct with mutated
Lef1/Tcf binding sites (FOP) (van de Wetering et al., 1997).
4OHT treatment led to a three-fold increase in luciferase
activity of the TOP construct in cells expressing D Nb -
cateninER but had no effect on the FOP construct (Fig. 1C).
4OHT had no effect on TOP or FOP activity in cells transduced
with GFP (Fig. 1C).
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Having established that D Nb -
cateninER was able to inducibly
activate transcription in cultured cells
we generated transgenic mice in
which the construct was expressed
under the control of the keratin 14
(K14) promoter (Fig. 1A). The K14
promoter is active in all the basal cells
of interfollicular epidermis and along
the length of the hair follicle outer
root sheath (Vassar et al., 1989; Byrne
et al., 1994; Wang et al., 1997). Four
K14∆Nb -cateninER founder lines
were chosen for analysis, based on
the range in transgene copy number
that they represented. Line 3953 has
a single copy of the transgene; line
D2 has 12 copies; line C5 has 18
copies and line D4 has 21 copies.
None of the mice exhibited any
phenotype in the absence of 4OHT.
Expression of the transgene was
examined by immunofluorescence
labelling of skin sections (Fig. 1D)
and by western blotting of cultured
primary mouse keratinocytes (Fig.
1E), using antibodies to the oestrogen
receptor. Epidermis from transgene-
negative mice did not express any
protein that could be detected with
the anti-ER antibodies (Fig. 1D,E). In
transgenic mouse skin that had not
been treated with 4OHT, cytoplasmic
staining for ER was detected in the
basal layer of the interfollicular
epidermis and along the outer root
sheath of the hair follicle with no
obvious cell to cell variation in levels
(Fig. 1D, middle panel). In 4OHT-
treated epidermis, nuclear staining
was evident in all transgene-positive
cells, although it was more intense in
the hair follicles than in the
interfollicular epidermis (Fig. 1D,
right panel and data not shown).
Nuclear staining for ER and b -catenin was similar (data not
shown). The level of D Nb -catenin ER protein correlated with
transgene copy number, with line 3953 keratinocytes
expressing the lowest level of the protein and line D4
keratinocytes expressing the highest level (Fig. 1E and data not
shown).
Consequences of activating b -catenin for different
lengths of time
In pilot experiments we applied 4OHT topically to the back
skin of transgenic and wild-type mice daily and assessed
whether there was any macroscopic change in phenotype (Fig.
1F and data not shown). The mice were 6 weeks old at the start
of treatment and were thus in the resting (telogen) phase of the
hair cycle. As a consequence, clipped wild-type animals did
not regrow hair, whether treated with 4OHT (Fig. 1F, left
panel) or with acetone vehicle (data not shown). The D2 line
(Fig. 1F, right panel) showed complete hair regrowth within 14
days. The 3953 line showed patchy hair regrowth (data not
shown) and as the histological changes were similar to D2,
only less pronounced, we did not study this line further. After
9 days of 4OHT treatment the skin of D4 transgenic mice was
very dark and wrinkled, and although new hair growth was
stimulated the hairs failed to fully elongate (data not shown).
The C5 line showed the same gross phenotype as line D4,
although the onset of the 4OHT-induced changes was slightly
later (data not shown).
We next performed a time course experiment in which we
analysed sections of back skin from D2, D4 and littermate
control mice at intervals for up to 14 days of daily 4OHT
treatment (Fig. 2). No effects of 4OHT on the back skin of
transgene-negative mice were seen (Arnold and Watt, 2001)
Fig. 2. Histological analysis of the effects of sustained b -catenin activation in back skin of
transgenic mice (lines D2 and D4). Arrows indicate outgrowths from the permanent portion of
hair follicles (days 7 and 14, line D2; day 3, line D4). Arrowheads indicate small empty cysts
(days 14, 21, line D2). Bracket indicates a region of hyperproliferative IFE (line D4, day 9).
Scale bar: 100 m m.
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(data not shown). 4OHT did not cause any changes in the
histology of the interfollicular epidermis in D2 mice, while in
the D4 line we observed occasional patches of
hyperproliferative epidermis (e.g. Fig. 2, day 9).
In the D2 line the first changes were visible at day 5 and
corresponded to an elongation and thickening of the hair
follicles. By day 7 there was pronounced elongation of the
follicles and by day 14 they were in full anagen (growth phase)
(Fig. 2). The main difference between the D2 follicles and
normal anagen follicles was the appearance of additional
epithelial outgrowths extending from the permanent portion of
the outer root sheath, usually below the level of the sebaceous
glands (Fig. 2, arrows, day 7, day 14).
In D4 transgenics an elongation of the hair follicles was
already visible 1 day after the beginning of 4OHT treatment
(Fig. 2). By day 3, epithelial outgrowths were developing from
the sebaceous glands (arrow in Fig. 2) and from the permanent
portion of the outer root sheath below the sebaceous glands.
Between day 5 and day 9 the follicles became progressively
thicker, with the outgrowths becoming larger. In contrast to the
hair follicles of D2 mice the D4 follicles tended not to produce
normal hair shafts and this probably accounts for the abnormal
macroscopic appearance of the pelage.
The D4 mice had to be sacrificed by day 11 and the C5 mice
by day 17 because they developed thickening of the lips and
tongue which affected their ability to feed. The D2 line could,
however, be maintained indefinitely with 4OHT treatment. By
day 21 the outgrowths from D2 hair follicles had become very
pronounced and small cyst-like structures, corresponding to
empty hair canals, had appeared (arrowhead, Fig. 2). The
histology of each D2 follicle from day 21 onwards resembled
a trichofolliculoma, a hair follicle tumour that has previously
been reported to be induced by constitutive overexpression of
stabilised b -catenin (Gat et al., 1998). At day 28, the follicles
of D2 epidermis were entering
catagen (regression phase) but the
tumours were still enlarging and
thus the epithelial outgrowths
accounted for most of the mass of
the follicles.
b -catenin induces de novo
hair follicle formation in
postnatal interfollicular
epidermis
In addition to the changes in
existing hair follicles (Fig. 2), de
novo hair follicle formation was
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Fig. 3. De novo hair follicle
formation in interfollicular
epidermis. (A-F) Histology of the
paw skin of (A,C,E) wild-type and
(B,D,F) transgenic (line D4) mice
treated daily with 4OHT for 1 week.
A,B are montages reconstructed
from images of sections covering the
entire circumference of the paw. The
boxed regions in A,B are shown at
higher magnification in C,E and D,F
respectively. Arrows in F indicate
new follicles arising from
interfollicular epidermis.
(G-J) Visualisation of alkaline
phosphatase activity (blue) as a
dermal papilla marker in back skin
(G) and paw (H-J) of transgenic
(line D4) mice 8 days after a single
application of 4OHT. Arrows in G
show alkaline phosphatase-positive
cells associated with the original
dermal papilla (lowest arrow) and
with new follicles arising from
interfollicular epidermis (top arrow)
and outer root sheath (middle
arrow). The boxed regions in H are
shown at higher magnification in I,J.
(I) Original dermal papilla; (J) Two
new rudimentary follicles. Scale
bars: 500 m m (A,B) 100 m m (C-J).
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observed in D2 and D4 transgenics (Fig. 3). This was
particularly striking in paw skin. On the dorsal surface of the
paw the density of follicles was higher in transgenics treated
with 4OHT for 7 days (Fig. 3B,F) than in littermate controls
(Fig. 3A,E). In the transgenic skin many downgrowths of
interfollicular epidermis into the underlying dermis were
observed, which had the appearance of rudimentary hair
follicles (arrows in Fig. 3F). On the dorsal region of the digits
of D4 mice the interfollicular epidermis was hyperproliferative,
with an excess of cornified material extending into the neck of
pre-existing hair follicles (Fig. 3F). The induction of new
rudimentary and mature hair follicles was not confined to the
paws, since new hair follicle formation was observed in dorsal
skin of D2 and D4 mice (Fig. 3G, and data not shown).
On the ventral surface of the paw (the foot pad) there are
regions of wild-type skin that are devoid of hair follicles and
the dermal/epidermal boundary is flat (Fig. 3A,C). In the
equivalent region of treated transgenics the boundary was more
complex, as a result of multiple epithelial projections into the
dermis, which had the appearance of rudimentary hair germs
(Fig. 3B,D) (Byrne et al., 1994). Similar alterations at the
dermal-epidermal boundary were seen also in the internal
surface of the ear of transgenic mice (data not shown).
At the base of wild-type follicles the epithelial cells ensheath
specialised mesenchymal cells, known as dermal papilla cells,
which express high levels of alkaline phosphatase (Van Mater
et al., 2003) (Fig. 3G,H,I). The mesenchyme adjacent to the
epithelial projections, both from existing follicles and the
interfollicular epidermis, had high alkaline phosphatase
activity (Fig. 3G,H,J). It thus appears that keratinocytes
expressing high levels of b -catenin are able to induce dermal
papillae.
One of the earliest features of de novo hair follicle formation
is upregulation of Sonic hedgehog (Shh) and its receptor
Patched (Ptc) (St-Jacques et al., 1998; Chiang et al., 1999),
which are required for the maturation of the hair germ at the
base of the follicle. We therefore used in situ hybridisation to
examine whether Shh and Ptc expression was increased in
response to activation of D Nb -cateninER (Fig. 4). In wild-type
anagen hair follicles expression of Shh was confined to a group
of matrix cells on one side of the bulb and Ptc was expressed
in all the adjacent cells (Fig. 4A-D, arrows) (Oro and Higgins,
2003). In 4OHT-treated D2 (Fig. 4E-H) and D4 (Fig. 4I-L)
back skin, Shh and Ptc were upregulated in the epithelial
outgrowths from existing hair follicles. In D4 back skin
follicles Shh expression was no longer asymmetric but rather
Fig. 4. Shh and Ptc expression. In situ hybridisation was performed on the dorsal skin of (A-D) untreated wild-type mouse with anagen
follicles, (E-H) D2 or (I-L) D4 transgenic mice treated with 4OHT for 7 days, and (M-P) on the dorsal paw skin of D4 transgenic mice treated
with 4OHT for 7 days. (B,F,J,N) Dark-field views of Shh in situ hybridisations in A,E,I,M, respectively. (D,H,L,P) Dark-field views of Ptc in
situ hybridisations in C,G,K,O, respectively. Arrows in B indicate asymmetric Shh expression in the bulb of the hair follicle, while the arrow in
D indicates more uniform Ptc expression in the bulb. Arrows in F,J show Shh expression in the outgrowths arising from the permanent portion
of the follicles. Arrowheads in J show abnormal symmetrical expression of Shh in the bulb of the hair follicle and the asterisk in N indicates
Shh expression in epithelial downgrowths in the interfollicular epidermis. Scale bars: 100 m m.
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was observed on both sides of the hair bulb (Fig. 4I,J). Shh and
Ptc were also expressed in the downgrowths of interfollicular
epidermis on the dorsal surface of the paws of D4 mice (Fig.
4M-P). The induction of Shh and Ptc in all the observed
epithelial outgrowths supports the conclusion that they are
rudimentary hair follicles.
Effects of b -catenin on proliferation and
differentiation
The proliferative status of the epidermis was examined by
BrdU incorporation into S phase cells (Fig. 5A-D) and by
expression of cyclin D1 (Fig. 5E,F), a known transcriptional
target of b -catenin signalling (Tetsu and McCormick, 1999).
By 5 days of 4OHT treatment there was increased proliferation
in the epidermis of transgenic mice, but no effect on
proliferation in the epidermis of wild-type littermate controls
(Fig. 5 and data not shown). In D2 and D4 mice the increase
in BrdU-positive cells occurred along the ORS, at the base of
the hair follicles and in the epithelial outgrowths from the
interfollicular epidermis and existing hair follicles, but not in
the interfollicular epidermis itself (Fig. 5B-D). In D4 mice the
increase in BrdU incorporation was more pronounced than in
D2 mice and BrdU-positive cells were often found in more than
one cell layer, reflecting the thickening of the ORS (Fig. 5B).
Except in the epithelial downgrowths there was no increase in
BrdU incorporation in the phenotypically normal
interfollicular epidermis of treated transgenics (Fig. 5B,C)
compared to wild-type mice (Fig. 5A). The expression of
cyclin D1 mirrored BrdU incorporation, with increased
labelling in the ORS, the epithelial outgrowths from the hair
follicles and interfollicular epidermis, and at the base
of follicles (Fig. 5E,F and data not shown).
The histological appearance of the epiderrmis and
induction of Shh and Ptc strongly suggested that D Nb -
catenin was inducing new hair follicle formation. For
further confirmation, we examined expression of a
range of markers of hair follicle differentiation (Fig. 6).
In wild-type follicles keratin 17 is expressed along the
outer root sheath (Fig. 6A) (McGowan and Coulombe,
1998), while the transcriptional repressor CCAAT
displacement protein (CDP), essential for normal hair
follicle inner root sheath formation, is confined to the
bulb (Fig. 6B) (Ellis et al., 2001). Trichohyalin is a
terminal differentiation marker expressed in cells that
are producing the hair shaft (O’Guin et al., 1992) (Fig.
6C) and Lef1 is localised in the matrix (Fig. 6D)
(DasGupta and Fuchs, 1999). In 4OHT-treated D2
transgenics expression of keratin 17 (Fig. 6E), CDP
(Fig. 6F) and Lef1 (Fig. 6H) was observed in the
outgrowths from the hair follicles, but the outgrowths
did not express trichohyalin (Fig. 6G). In D4 mice all
four markers were expressed in the new follicles
forming from interfollicular epidermis and pre-existing
follicles (Fig. 6I-L). These results support the
conclusion from the histological examination of the
skin (Figs 2, 3) that b -catenin promotes hair lineage
differentiation. The increase in proliferation (Fig. 5)
coincided with, rather than preceded, the ectopic
expression of hair differentiation markers (Fig. 6).
We also examined markers of interfollicular
epidermal differentiation and sebocyte differentiation
(Figs 7, 8). No changes in the morphologically normal
interfollicular epidermis were observed using
antibodies to keratin 1 and 10 and the small cysts in
D2 follicles did not express these keratins (data not
shown; see also Fig. 8K). Using fatty acid synthase as
a marker of sebaceous differentiation (Kusakabe et al.,
2000) (Fig. 7A,B) we frequently observed duplication
of the sebaceous glands in D2 and C5 epidermis
during the first 15 days of 4OHT treatment (data not
shown and Fig. 7C). At later time points there was loss
of morphologically identifiable sebaceous glands in
D2 skin and sebocytes were found only in small
clusters in a scattered distribution in the
trichofolliculomas (Fig. 7D). In the D4 line sebaceous
gland differentiation was lost within 9 days (Fig. 7E).
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Fig. 5. Analysis of proliferation in back skin of (A) wild-type or (C,E) D2
transgenic mice and in (B,D,F) paw skin of D4 transgenic mice. (A-D) BrdU
labelling (green) with propidium iodide nuclear staining (red). Green
fluorescence of hair shafts is non specific. (E,F) Cyclin D1
immunohistochemistry (brown) with Haematoxylin counterstain (blue). Mice
were treated with 4OHT for the periods indicated. Arrows in C and E indicate
outgrowths arising from the hair follicles that are positive for BrdU and Cyclin
D1, respectively. Scale bars: 100 m m.
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This suggests that sustained activation of b -catenin signalling
promotes differentiation along the hair lineages at the expense
of sebaceous differentiation.
Transient activation of b -catenin is sufficient to
induce anagen and de novo hair follicle formation
but not to sustain trichofolliculomas
To investigate whether transient activation of b -catenin was
sufficient to induce anagen in existing follicles, de novo follicle
formation and hair follicle tumours, the three phenotypes
caused by repeated 4OHT applications, we carried out kinetic
experiments that are summarised in Fig. 8A. Each black spot
represents a time point examined. Continuous lines represent
continuous daily applications of 4OHT and the dotted lines
represent periods when no 4OHT was given.
In D2 and D4 mice a single application of 4OHT induced
the same changes as seven daily treatments (Fig. 8B-D;
compare Fig. 2). One dose of 4OHT was sufficient to induce
anagen and epithelial outgrowths from hair follicles in D2 mice
(Fig. 8B; compare Fig. 2). One dose of 4OHT induced
thickening of the hair follicles (Fig. 8C) and epithelial
outgrowths from the outer root sheath (Fig. 8C) and
interfollicular epidermis (Fig. 8D) in D4 skin (compare with
Fig. 2). Similarly, mice treated for 5 days with 4OHT and then
examined after 5 or 10 days (Fig. 8A) were phenotypically
Fig. 6. Expression of hair follicle differentiation markers. (A-D) Untreated wild-type anagen follicles. (E-H) Dorsal back skin of D2 transgenic
mice treated with 4OHT for the periods indicated. (I-L) Dorsal paw skin of D4 transgenic mice treated with 4OHT for 5 days. Paraffin sections
were immunostained with (A,E,I) anti-keratin 17, (B,F,J) anti-CDP, (C,G,K) anti-trichohyalin, or (D,H,L) anti-Lef1 antibodies and
counterstained with Haematoxylin. Arrows in F and H indicate positive staining in the epithelial outgrowths from pre-existing follicles. Scale
bar: 100 m m.
Fig. 7. Effect of b -catenin activation on sebocyte differentiation.
Immunolocalisation of fatty acid synthase in dorsal back skin of (B)
untreated wild-type mouse skin, (C) C5 transgenic treated with
4OHT for 15 days (arrows highlight duplication of sebaceous gland),
(D) D2 transgenic treated with 4OHT for 28 days and (E) D4
transgenic treated with 4OHT for 9 days. A is wild-type follicle
stained with secondary antibody only (bracket indicates the
sebaceous gland). Scale bars, 100 m m.
1796
indistinguishable from mice treated continuously for 10 or 15
days (data not shown).
In contrast to the ability of transient b -catenin activation to
induce anagen and de novo follicle formation, continuous b -
catenin expression was required to maintain hair follicle
tumours (Fig. 8E-G). The tumours observed after 28 days of
continuous b -catenin activation (Fig. 8E) started to regress
after 4OHT treatment had ceased (Fig. 8F). The skin did not
return completely to normal, however, as the hair follicles
retained small epithelial outgrowths and cysts as late as 106
days after 4OHT treatment had stopped (Fig. 8G). Remarkably,
in ear skin the tumours continued to expand for about 2 weeks
in the absence of 4OHT before regression began (data not
shown). While the tumours induced by continuous b -catenin
activation were positive for cyclin D1 (Fig. 8H), Lef1 (Fig. 8I)
and keratin 17 (Fig. 8J), during regression Lef1 and cyclin D1
expression were lost (Fig. 8L and data not shown). The residual
tumour masses remained positive for keratin 17 (Fig. 8M) and
negative for the interfollicular epidermal marker keratin 1 (Fig.
8K). Whereas the tumours showed strong staining for nuclear
b -catenin (Fig. 8N,O) this was lost when the tumours regressed
(Fig. 8P,Q).
Discussion
The keratin 14 promoter cassette developed by Fuchs
and co-workers has been an immensely valuable
reagent for directing transgene expression in the
proliferative compartment of mouse interfollicular
epidermis, sebaceous gland and hair follicle outer
root sheath (Vassar et al., 1989; Byrne et al., 1994;
Wang et al., 1997). It has been used to manipulate b -
catenin signalling in several different transgenic
models, thereby demonstrating that b -catenin plays a
key role in epidermal lineage commitment (e.g. Gat
et al., 1998; Merrill et al., 2001; Niemann et al.,
2002; DasGupta et al., 2002). However, the
endogenous promoter is first active at E9.5, before
the hair placodes form (Byrne et al., 1994), and so it
is possible that transgene expression during
embryonic development is necessary to render the
epidermis responsive to changes in b -catenin
signalling in postnatal life. In order to establish
whether the epidermis is truly capable of undergoing
lineage conversion in adulthood we generated an
inducible form of b -catenin under the control of the
K14 promoter. This allowed us to activate b -catenin
signalling exclusively in postnatal epidermis and to
investigate the effects of activating b -catenin for
different lengths of time. A similar approach has
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Fig. 8. Effects of transient b -catenin activation in
K14D Nb -cateninER transgenic mice. (A) Schematic
representation of experiments performed with the D2 and
D4 transgenic lines. The arrow represents time in days
(not to scale). Dots are time points analysed. Continuous
lines connecting dots represent periods of daily 4OHT
treatment and dashed lines indicate no 4OHT treatment.
(B-G) Mice received the number of doses (d) of 4OHT
indicated and were kept without 4OHT for number of
days shown (+). (B,C,E-G) Back skin, (D) paw skin.
Arrows in B and C indicate epithelial outgrowths from the
permanent portion of the hair follicles and from
sebaceous glands. Arrows in D indicate new hair buds
arising from interfollicular epidermis. (H-Q) expression
of cyclin D1 (H), Lef1 (I,L), keratin 17 (J,M), keratin 1
(K) and b -catenin (green, N-Q; red fluorescence is
propidium iodide counterstain) in D2 tumours, after 28
days of 4OHT treatment (H-J,N,O) or 28 days of
treatment followed by 28 (P,Q) or 106 days (K-M)
without 4OHT. Arrows in I highlight Lef1 expression.
O,P are high magnification views of boxed regions in N,
Q respectively. Scale bars: 100 m m (A-M), 50 m m (N-Q).
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recently been described by Van Mater et al. (Van Mater et al.,
2003) who found, as we did, that transient b -catenin activation
is sufficient to induce hair follicles to enter the growth phase
(anagen) of the hair cycle. In addition we show that b -catenin
induces de novo hair follicle formation in interfollicular
epidermis and can cause either duplication of the sebaceous
glands or inhibition of sebocyte differentiation depending on
the level of activation. These results reveal a remarkable
plasticity in the differentiation potential of adult epidermis.
In all of the K14 D Nb -catenin lines the first effect of applying
4OHT to skin with telogen (resting) hair follicles was to induce
anagen. In D2 mice the anagen was essentially normal and the
coat of fur that grew could not be distinguished
macroscopically from a wild-type pelage. However, in D4
mice, which have a higher transgene copy number and express
a higher level of D Nb -catenin, the degree of proliferation
induced by 4OHT was greater than in normal anagen with the
result that the follicles became abnormally thickened and failed
to produce normal hair shafts. Anagen was induced as
effectively by transient as by continuous activation of b -catenin
(see also Van Mater et al., 2003). Conversely, anagen did not
continue indefinitely, since follicles in epidermis treated with
4OHT for 28 days were shorter than follicles treated for 21
days, demonstrating that additional factors are required for
maintenance of hair growth (Fuchs et al., 2001).
Shh is a target gene of b -catenin in the epidermis (Gat et al.,
1998; Huelsken et al., 2001) and was induced by activation of
D Nb -cateninER. Shh is expressed in the bulb of growing wild-
type follicles and is known to initiate anagen (Oro et al., 1997;
St-Jacques et al., 1998; Sato et al., 1999; Wang et al., 1997;
Callahan and Oro, 2001; Stenn and Paus, 2001). It therefore
seems likely that the reason for the entry of transgenic follicles
into anagen was that Shh was induced by D Nb -cateninER.
Levels of Shh and its receptor Ptc, itself a Shh target (Freeman,
2000), were higher in D4 than in D2 epidermis and whereas in
wild-type and D2 follicles Shh expression was asymmetric, in
D4 follicles expression was observed on both sides of the hair
bulb. Thus, aberrant Shh levels and localisation may contribute
to the abnormalities in D4 anagen follicles.
De novo follicle formation was a striking phenotype of
K14D Nb -cateninER mice and established that b -catenin can
induce new follicles even when expression is restricted to
postnatal epidermis (cf. Gat et al., 1998). Rudimentary follicles
developed as epithelial outgrowths from the permanent portion
of the outer root sheath, from sebaceous glands and from
interfollicular epidermis. Such outgrowths also formed on the
ventral surface of the paw and in the internal surface of the ear,
regions normally devoid of hair follicles. Dermal cells adjacent
to the outgrowths had high alkaline phosphatase activity, a
marker of dermal papilla cells. At later times the base of the
new follicles was seen enveloping a dermal condensate that
was morphologically indistinguishable from a dermal papilla
(data not shown).
All of the outgrowths expressed Shh, Ptc, K17, CDP and
Lef1, markers of hair follicle formation (Millar, 2002;
McGowan and Coulombe, 1998; Ellis et al., 2001; Zhou et al.,
1995). Whether the outgrowths progressed to form complete
hair follicles with hair shafts and trichohyalin expression
depended on the duration of b -catenin activation, complete
follicles appearing from 14 days onwards. The level of b -
catenin appeared to determine the number of new follicles
developing from interfollicular epidermis: in the D4 transgenic
line there were more new follicles and the initial outgrowths
appeared in a shorter time than in the D2 line.
The formation of hair follicles during embryogenesis
depends on a series of signals that are exchanged between the
epidermis and the underlying dermis (Hardy, 1992; Millar,
2002). In the embryo the initiating signal comes from the
dermis and involves activation of Wnt signalling (Kishimoto
et al., 2000); the response in the overlying epithelium also
involves activation of b -catenin. In K14 D N b -cateninER skin
the dermal signal is not required and activation of b -catenin
signalling in the epidermis leads to organisation of a dermal
papilla (Fig. 3G-J). In each location where new follicles
formed in K14 D N b -cateninER epidermis there was induction
of Shh, Ptc and Lef1. Just as Shh drives anagen, Shh is
downstream of Wnt signalling in hair follicle development
(Fuchs et al., 2001; Millar, 2002): in mice lacking Shh hair
follicle formation is initiated and the dermal condensate is
formed but mature hair follicles fail to develop (St-Jacques et
al., 1998; Chiang et al., 1999). Lef1 is a known transcriptional
target of b -catenin (Filali et al., 2002), required for normal
hair follicle formation (van Genderen et al., 1994; Zhou et al.,
1995; Kratochwil et al., 1996). Although during normal hair
placode formation expression of Lef1 is regulated by Noggin,
produced by dermal cells (Jamora et al., 2003), in our system
Lef1 upregulation is independent of a pre-existing dermal
signal.
The effects of prolonged activation of D Nb -cateninER were
not confined to hair follicle differentiation. While
differentiation within the interfollicular epidermis was largely
normal there were also some areas of hyperproliferation,
leaving open the question of whether b -catenin can expand the
size of the IFE stem cell pool (Zhu et al., 1999; Reya et al.,
2003). The effects on sebocyte differentiation were even more
puzzling, because there was initial duplication of sebaceous
glands, but thereafter sebocytes were lost; in D4 epidermis no
sebocytes were detectable by 9 days of 4OHT treatment. c-Myc
is induced by b -catenin (He et al., 1998) and direct activation
of c-Myc in adult epidermis stimulates sebocyte differentiation
in both the sebaceous glands and interfollicular epidermis
(Arnold and Watt, 2001; Braun et al., 2003). However, when
b -catenin signalling is blocked with a D NLef1 transgene there
is ectopic sebocyte differentiation and sebocyte tumours appear
(Niemann et al., 2002; Braun et al., 2003). One interpretation
of these results is that sebocyte differentiation is promoted by
intermediate levels and duration of b -catenin signalling and
blocked by higher levels and duration. The phenotype of
epidermis expressing D NLef1 demonstrates that sebocyte
differentiation can be promoted independently of b -catenin
activation, presumably through the ability of D NLef1 to
interact with other pathways (Labbe et al., 2000).
Just as b -catenin levels regulate lineage choice in the
epidermis so they also influence the types of tumour that
develop when signalling is deregulated (Owens and Watt,
2003). High b -catenin expression results in hair follicle type
tumours (Gat et al., 1998; Chan et al., 1999) whereas inhibition
of b -catenin signalling with D NLef1 leads to the formation of
sebaceous tumours at high frequency (Niemann et al., 2002;
Niemann et al., 2003). The tumours induced by sustained
activation of D Nb -cateninER were highly differentiated and
resembled human trichofolliculomas, consistent with the
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earlier observations of Gat et al. (Gat et al., 1998) and Chan et
al. (Chan et al., 1999). Every follicle in which D Nb -catenin
was activated for 21 days developed into a tumour. However,
once b -catenin activation ceased all the tumours regressed, and
by three months what remained were remnants of the tumour
mass that mainly consisted of empty hair shafts. Thus
continued b -catenin activation was needed to maintain the
tumours, and they could not grow autonomously. One reason
may be that b -catenin induces p53, which serves to limit
growth (Damalas et al., 2001). Additional oncogenic changes,
such as mutation of p53 or Ras, would be necessary to convert
the trichofolliculomas into malignant tumours capable of
autonomous growth (Hahn and Weinberg, 2002; Perez-Losada
and Balmain, 2003; Owens and Watt, 2003).
Considerable debate surrounds the degree of plasticity of
adult stem cells (Alison et al., 2003; Goodell, 2003). While the
current consensus is that the ability of adult stem cells to
undergo conversion into unrelated cell types is limited (e.g.
Wagers et al., 2002), interconversion between epidermal
lineages can be readily induced. The present studies show that
b -catenin can induce de novo hair follicle formation from
existing follicles, interfollicular epidermis and sebaceous
glands, and it has previously been reported that c-Myc induces
sebocyte differentiation in interfollicular epidermis (Braun et
al., 2003). Thus all regions of the epidermis are competent to
undergo lineage conversion. We and others have argued that
there are distinct stem cell pools in IFE, sebaceous glands and
hair follicles (reviewed by Niemann and Watt, 2002). The
challenge now is to find out whether only stem cells are capable
of undergoing reprogramming or whether plasticity is also
retained in committed progenitors (Braun et al., 2003).
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reagents, and to the Cancer Research UK Biological Resources Unit,
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